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CRITICAL REVIEW
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Significance: Skin tissue damage is a major challenge and a burden on
healthcare systems, from burns and other trauma to diabetes and vascular
disease. Although the biological complexities are relatively well understood,
appropriate repair mechanisms are scarce. Three-dimensional bioprinting is
a layer-based approach to regenerative medicine, whereby cells and cell-based
materials can be dispensed in fine spatial arrangements to mimic native tissue.
Recent Advances: Various bioprinting techniques have been employed in
wound repair-based skin tissue engineering, from laser-induced forward
transfer to extrusion-based methods, and with the investigation of the ben-
efits and shortcomings of each, with emphasis on biological compatibility and
cell proliferation, migration, and vitality.
Critical issues: Development of appropriate biological inks and the vascu-
larization of newly developed tissues remain a challenge within the field of
skin tissue engineering.
Future Directions: Progress within bioprinting requires close interactions
between material scientists, tissue engineers, and clinicians. Microvasculariza-
tion, integration of multiple cell types, and skin appendages will be essential for
creation of complex skin tissue constructs.
Keywords: 3D printing, wound repair, skin tissue engineering, biofabrication
SCOPE AND SIGNIFICANCE
The application of tissue en-
gineering has been beneficial in
improving wound treatment and
alleviating the skin donor problem.1
However, as the skin is a complex
structure containing pigmenta-
tion, vessels, hair follicles, and dif-
ferent cell types, integrated into
a dynamic structure with different
properties distributed throughout,
many challenges remain.2,3 Ideally,
tissue-engineered constructs mimic
both structural organization and
biological function in native tissue.4
Bioprinting, an additive manufactur-
ing technique used for combining
biological components and bioma-
terials in a structured manner, shows
promise in this imitation process due
to the improved three-dimensional
(3D) spatial control of the multiple
components that can be introduced
within a single construct.5 Therefore,
significant improvements in the de-
velopment of tissue-engineered skin
grafts can be made with bioprinting.
In addition, a better understanding
of dermatological diseases can be ach-
ieved via a thorough understanding
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of the mechanisms involved in wound healing,
using the continuously developed skin constructs.6
The knowledge accrued can further expedite the
development of bioprinting platforms to deliver
skin constructs with optimal biological functions.
Further, it may provide economic advantages and
improve reproducibility of the constructs.5
TRANSLATIONAL RELEVANCE
In small wounds, the stratum basale of the epi-
dermis is capable of regenerating the epidermis of
the skin. However, when the stratum basale is af-
fected and the dermis is damaged, regeneration is
delayed and scarring will occur. Bioprinting tech-
niques may contribute to skin tissue engineer-
ing, by creating precisely controlled spatial cell
arrangements within a construct, mimicking the
multiple layers found in native skin, and replacing
the regenerative elements of the skin. In this man-
ner, damaged skin could be restored and the amount
of scar formation decreased. This is of particular
importance within chronic wounds, wounds beyond
the epidermis, and large area wounds, as the natural
regeneration process is restricted. By offering the
potential to better simulate the anatomical structure
of the skin in a controllable and reproducible man-
ner, bioprinting represents an appealing approach
to improve the efficacy of cell therapy for treatment
in full-thickness and complex skin wounds.
CLINICAL RELEVANCE
A range of tissue-engineered skin grafts have
been developed, and some of them have been ap-
proved for clinical utilization. These include epi-
dermal, dermal, and epidermal/dermal substitutes.
However, for most applications, tissue-engineered
skin has yet to supplant the current gold standard
of a split-thickness autograft. Approaches that en-
able effective skin wound repair and regeneration of
clinical relevance are required. Bioprinting provides
a reproducible method for mass production of bio-
logical and mechanical appropriate constructs with
a high spatial organization of cells. Clinically, the
introduction of cell-laden biofabricated constructs
may accelerate wound healing and reduce scarring
at sites of injury, thereby increasing quality of
life. The possibilities in increasing the control of
spatial integration of biomaterials and cells in the
3D printed skin constructs may improve on the re-
generation process, possibly decreasing necessary
intervention, thereby increasing the efficiency of
cell therapy and decreasing the strain on the med-
ical system. Further, the development of new skin
substitutes may also improve the manageability
for the clinician. Lastly, the creation of skin sub-




The skin provides a protective barrier with im-
munologic and sensorial functions. It prevents
the invasion of harmful substances and pathogens,
such as bacteria, and protects against loss of mois-
ture and electrolytes.7–9 When damaged, a natural
regeneration process is initiated, which consists of
three distinct phases: the inflammatory, new tissue
formation, and tissue remodeling phases. However,
when the wound encompasses all skin layers and/or
regenerative elements, healing is delayed or in-
hibited. Consequently, inadequately vascularized
scar tissue can be formed.8,10 To enhance the heal-
ing process, dressings and (synthetic) skin grafts
have been applied to the damaged area. However,
current treatments are insufficient in extensive
burns, chronic wounds, and other wounds that in-
volve the loss of large amounts of skin. Hence, there
is an overwhelming need for the development of new
skin replacement strategies.
To develop a skin substitute, it is important to
understand formation, mechanical properties, and
cellular composition of the skin.11 Healthy skin
consists of three main components: the epidermis,
dermis, and hypodermis (Fig. 1).12 The epidermis,
containing mainly keratinocytes, is primarily re-
sponsible for the barrier function of the skin, in-
cluding the prevention of harmful pathogens from
entering the body. It is structured from the outer
layer to the inner layer of the stratum corneum,
stratum lucidum, stratum granulosum, stratum
spinosum, and the stratum basale. Underneath the
stratum basale the connecting layer can be found
between the epidermis and the dermis, known as
the basement membrane zone. The dermis consists
of fibroblasts and extracellular matrix (ECM) com-
ponents (collagen and elastin), blood vessels, nerves,
and appendageal structures. It is composed of two
layers, the papillary dermis (the upper layer), which
is responsible for the prevention of sliding between
the epidermis and the dermis and the provision of
oxygen and nutrients to the epidermis, and the re-
ticular dermis, which is mainly responsible for the
mechanical properties of the skin. The hypodermis
consists mostly of adipose tissue.13
Wound treatment
Traditional wound dressings, such as bandages
and gauze, are used regularly to provide protec-
tion against pathogens and other environmental
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hazards to stimulate appropriate wound healing.
However, as they absorb fluid extrusions and ad-
here to the wound, and induce damage on removal,
application of dressings may lead to impairment of
proper healing.14 Modern wound dressings have,
thus, been developed to overcome the limitations by
promoting the healing process in a moist environ-
ment. Examples of modern dressings include hy-
drocolloids, alginate, and nonalginate dressings.15
Wound treatments have been adapted to incorpo-
rate bioactive molecules, such as growth factors and
antimicrobial molecules.
For treatment of large area skin loss, including
severe burns, wound dressings are not sufficient.
Thus, skin grafts, where a piece of healthy skin
from a donor area, either partial thickness (split
skin) or full thickness or containing only epidermis,
is harvested and applied to the wound, are often
required to accelerate wound coverage and healing.
For epithelial autografting, epidermal cultures of
a patient’s keratinocytes have been explored, to
form confluent cell sheets. This has proved time-
consuming and costly. An alternative approach has
been developed, where autologous cells are used
in suspension and applied directly to a wound
surface by using a spray-on technique. This method
shows increased applicability to clinical situations,
and offers the potential to facilitate one-stage
treatment for partial thickness burns, and full-
thickness wounds when combined with a dermal
regeneration template.16,17
Currently, autografts are a preferred method as
they provide good adhesion and pain relief, with
minimal rejection of the graft. This method is in-
herently limited by the availability of donor sites
and also, it leads to further trauma, potentially
resulting in additional complications. Allografts
gained popularity owing to their higher availabil-
ity. However, in most cases, they provide only tem-
porary ‘‘biological dressings.’’ Concerns remain
especially regarding immunological rejection, dis-
ease transmission, sensitization of the recipient,
and ethical considerations. The limitations and
developments mentioned earlier have prompted
the advance of skin tissue engineering and syn-
thetic skin grafts.10 For a comprehensive review
on wound treatments, the readers are referred to
Boateng et al.18
Figure 1. Anatomy of the skin.12 Permission obtained from McGraw-Hill Education. To see this illustration in color, the reader is referred to the web version of
this article at www.liebertpub.com/wound
3D PRINTING AND CELL THERAPY FOR WOUND REPAIR 147
Skin tissue engineering
A contemporary and evolving process involves
skin tissue engineering. These skin replacements
are generally designed to remain within the skin
and degrade over time to reduce damage induced
on removal. By combining scaffolds with cells and
biomolecules, attempts are made to replace the
skin with a biological and mechanically sufficient
replacement to restore tissue function. However,
the synthetic skin grafts are often difficult to han-
dle, with poor adhesion to the wound bed, poor
vascularization, no promotion of regeneration of
full-thickness wounds, and high manufacturing
costs.14 One of the main causes of these complica-
tions is the relative simplicity of the current tissue-
engineered constructs.19 To restore the skin to its
natural healthy conditions, the tissue replacement
should closely resemble the skin layering and
composition. Due to the complexity of the skin, the
development of a functional replacement tissue
remains challenging. Generally speaking, to engi-
neer skin substitutes, four key requirements must
be met: (1) Engineered skin must be able to pro-
vide a moist environment; to promote healing and
prevent attachment of the dressing to the sur-
rounding tissues. (2) Engineered skin must be able
to enhance natural wound-healing responses. (3)
Replacement tissue must also be able to provide
adequate oxygen exchange with the surrounding
environment. (4) It must limit the infiltration of
potential harmful bacteria and pathogens.14,20
Other considerations in the engineering of skin
substitutes are patient safety, degradation time,
duration of cover, shelf life, cost, mechanical sta-
bility, adequate vascularization, and number of
stages for completion of treatment.21 Preferably, a
replacement has the structural composition and
mechanical properties that are similar to the ECM
of the skin.22 Tissue-engineered skin substitutes
currently applied are epidermal substitutes, der-
mal substitutes, and dermo-epidermal substi-
tutes.23,24 Epidermal substitutes are often cultured
(split thickness) epithelial autografts that can be
used in extensive burns. However, they have the
same disadvantages as with most of the autografts:
high infection risk, high cost, limited collection
site.22 Examples of dermal substitutes used in a
clinical setting are Integra, AlloDerm, Derma-
graft, and Matriderm. The application of In-
tegra, AlloDerm, or Dermagraft involves a
two-step process.19 Integra, a crosslinked bovine
collagen-based matrix, has a good long-term aes-
thetic and functional outcome, but with high cost
and a poor adhesion to wound site. AlloDerm,
human acellular dermis in a lyophilized form,
provides a matrix closely resembling the patients’
skin delivering good vascularization and regenera-
tion. This method is restrained by high costs, dis-
ease transmission between donors. Dermagraft,
a synthetic material made from bioabsorbable
polyglactin seeded with neonatal human foreskin
fibrolasts, improves ease of handling for the sur-
geon, shows no rejection, and can be applied on
chronic wounds; however, poor ECM structures,
infections, and cellulitis have been reported.
Matriderm, a noncrosslinked lyophilized bovine
material, is a one-stage process that promotes
vascularization and improves stability and elastic-
ity of regenerated tissue.22 This material, currently
used for dermal grafts, has also been applied as an
ink material in biofabrication. Lastly, examples
of dermo-epidermografts are PermaDerm and
DenovoSkin, which more closely resemble the na-
tive skin, but no clinical trials have been reported
as of yet.23 For more comprehensive overviews of
current skin substitutes, refer to Hrabchak et al.,
Metcalfe and Ferguson, or Chua et al.3,19,23
Tissue-engineered skin can be enhanced by the
addition of growth factors and other biomolecules,
regulating several wound-healing-related pro-
cesses, as the ECM has been an important factor
in growth factor regulation and delivery.25 Major
growth factors and cytokines that can be added to
modulate wound healing are epidermal growth
factor (EGF), basic fibroblast growth factor (bFGF),
transforming growth factor-b (TGF-b), platelet-
derived growth factor (PDGF), vascular endothelial
growth factor (VEGF), interleukin (IL)-1, IL-6, and
tumor necrosis factor-a (TNF-a). These influence re-
epithelialization, granulation tissue formation,
matrix formation and remodeling, and inflamma-
tion levels.26,27 When added unaided, proteases at
the wound site have shown to interfere with efficacy.
Therefore, combining growth factors with wound
dressings and/or tissue-engineered skin grafts im-
proves healing by creating an appropriate wound
environment. To improve the therapeutic efficacy of
growth factors, a number of delivery strategies have
been developed to enable controlled spatial/temporal
presentation of growth factors at the site of injury.
These include, for example: lipid nanoparticle sys-
tems, ECM-inspired growth factor delivery systems,
and nanofibrous structures.27,28 Due to the limited
scope of this article, readers are referred to a couple
of excellent reviews by Gainza et al., Barrientos
et al., and Pachuau.26–28
Improvements in tissue-engineered skin sub-
stitute healing can be made in regards to the high
manufacturing costs, regeneration of the skin, im-
mune rejection, ease of handling, and complexity of
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construct to closer resemble the anatomy of the skin.
High manufacturing costs may be addressed by the
use of bioprinting, which would reduce manual la-
bor and also bring standardization to the fabrication
process to produce reproducible skin substitutes.
Bioprinting
Bioprinting is an emerging additive manufactur-
ing tool in tissue engineering and regenerative
medicine. Using a computer-aided design, it provi-
des an unprecedented ability to strategically as-
semble biomaterials and cells to build 3D structures.
Bioprinting provides an economically viable and
reproducible method for the creation of spatially
organized, biologically compatible, and mechani-
cally stable constructs, mimicking the natural
organization of healthy skin. In addition, patient-
specific wound dressings and skin substitutes
could be fabricated with embedded ECM compo-
nents, growth factors, and cell types, precisely
tailored to each region and wound depth, facili-
tating the body’s natural response to trauma while
protecting the wound site.10
For bioprinting, core elements involve the type
of printer and bioink formulation, which act in
concert to determine the printing method and
process, and subsequently the biological and me-
chanical characteristics of the 3D printed construct.
Key modalities of printing that have been explored
for cell printing are inkjet printing, laser-induced
forward transfer (LIFT), and extrusion printing
(discussed in the next section). The materials used
to build the 3D construct are constituent of the
bioinks; these materials comprise synthetic and/or
naturally derived polymers, and they are employed
to facilitate cell printing and to provide extracellular
environments to support cell proliferation and/or
differentiation as required.
Bioprinting modalities and bioink
In inkjet printing, a cartridge is filled with a
bioink, which is dispensed in droplets onto the col-
lector plate via thermal or acoustic forces (Fig. 2).4
For thermal printing, pressure pulses are created
by electrically heating the print head. Acoustic
printing applies an acoustic wave to eject drop-
lets.29–31 The size of the droplets can be controlled
by regulating various parameters, such as temper-
ature and viscosity of the bioink, and the amplitude
and frequency of the printing parameters.30
As with all bioprinting approaches, inkjet
printing has its advantages and limitations. Re-
garding thermal approaches, inks are exposed to
temperatures over 200C for short bursts, and so
the capacity of inks to recover from abrupt temper-
ature change is critical. Interestingly, the impact on
encapsulated cells appears to be negligible.32,33
Another significant limitation relates to the me-
chanical stresses imposed on encapsulated cells,
with a considerably narrow viscosity tolerance
range.34 Moreover, frequent nozzle clogging and
inconsistent droplet formation impart further
difficulties. Therefore, bioinks used within this
technique should remain within a 3.5–12 mPa/s
viscosity range and low cell densities (typically
<106 cells/mL) are usually employed.35 Despite
these limitations, however, printing resolution
can be high, enabling precise positioning of cells.34
In addition, the availability of such printers is
vast, generally resulting in low maintenance and
service costs.
LIFT within the field of bioprinting is often re-
ferred to as LAB or LABP (Fig. 3).36 Unlike inkjet
printing, LIFT does not require a printing nozzle,
subjugating particular limitations in regards to
clogging of the nozzle. Figure 3 illustrates a simple
representation of the technology, where a donor
Figure 2. Schematic representation of an inkjet printer.
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layer, containing an energy-absorbing layer com-
monly made of gold or titanium but also polymers
such as gelatine or triazine, is excited through la-
ser pulses.37,38 These pulses penetrate and vaporize
the donor layer, creating a vapor bubble. The formed
hydrogel jet cascades onto the collector slide as a
fine resolution droplet with high spatial control.39
Droplet size can be regulated by laser energy, hy-
drogel depth, and viscosity.40 The ink viscosity
ranges for LIFT methods are not as narrow as inkjet
methods, 1–300 mPa/s compared with 3.5–12 mPa/s.
Correspondingly, nozzle, needle, and/or tip clogging
are not an issue.36
Arguably the most extensively explored bioprint-
ing approach in tissue engineering so far involves
microextrusion.41–43 Instead of droplets, extrusion
bioprinting dispenses continuous cylindrical strands
of hydrogel by using air or mechanical force
(Fig. 4).44–46 The former system employs pneu-
matics to drive the filament through the tip, which
is restricted only by pressure and the delay of its
volume. Mechanical or robotic extrusion print-
ers use either piston or screw mechanisms to
project hydrogels, with modest spatial control and
resolution.
Due to relative simplicity, ink properties for ex-
trusion printing are less restricted compared with
other approaches, supporting a vast viscosity range
of 30 mPa/s to at least 6 · 107 mPa/s.30 The cell
density can also be increased significantly, there-
fore making it possible to achieve physiological
relevant cell densities. In addition to cell sus-
Figure 3. A schematic representation of LIFT. LIFT, laser-induced forward transfer.
Figure 4. A schematic representation of an extrusion printer.
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pensions, cell pellets, tissue spheroids, and tissue
strands have also been successfully printed.46–49
A significant shortcoming of extrusion-based
bioprinting, apart from the resolution (hundreds
of microns), involves the shear stresses experi-
enced by encapsulated cells during printing.
High viscosities result in enhanced shape fidelity
at the expense of high shear stress. Thus, to
achieve both high cell viability and shape fidelity,
a bioink should demonstrate shear-thinning be-
havior during printing and then rapid recovery
or cessation after extrusion.43 Ink viscosity de-
termines printability and cell viability, which
are influenced by polymer concentration and
crosslinking. Coupled with these material prop-
erties are the hardware restrictions bestowed on
inks, ranging from, but not restricted to, pres-
sure, flow rate, temperature, and substrate in-
teractions.35,50
Skin printing
In recent years, skin printing has gained popu-
larity in the field of skin tissue engineering. Sev-
eral printing techniques have been applied in the
attempt of skin tissue formation. In 2009, Lee et al.
applied a stage-controlled inkjet printer to create
a layer-by-layer construct containing both primary
adult human dermal fibroblasts and primary
adult human epidermal keratinocytes, which were
printed in a polydimethylsiloxane mold simulating
a nonplanar skin wound. The artificial skin was
constructed by printing layers of collagen, onto
which a layer of cells could be deposited. After each
layer, the cell-containing gel was crosslinked by
using nebulized NaHCO3 vapor. The design con-
sisted of 10 layers of collagen, the second layer
seeded with fibroblasts, and the eighth layer con-
taining keratinocytes (Fig. 5A). Viability after
printing was comparable to the control group for
both fibroblasts (>95%) and keratinocytes (>80%),
indicating minimal damage due to inkjet printing
and shear stresses. However, an inhomogeneous
organization of the printed cells was still present.13
An alternate method was described by Lee et al.,
where an alternate spatial organization of collagen
layers was applied. To approach the structure and
spatial cell organization of native skin, keratino-
cytes were printed with a high density in the two
upper layers, whereas a lower density of fibroblasts
was printed into three layers equally distributed
throughout the remaining construct (Fig. 5B).13
The 3D printed constructs were better able to retain
their shape after 7 days of culture, compared with
manual deposition.51 Potential of inkjet printing in
Figure 5. Construction of two designs of layer-by-layer printing of collagen, human dermal fibroblasts, and keratinocytes. (A) Illustrates the design containing
10 layers, with layer 2 consisting of collagen and embedded fibroblasts, and layer 8 containing keratinocytes. Obtained and modified from13 with permission
from Elsevier. (B) Illustrates the method containing 2 top layers containing keratinocytes and 3 layers of fibroblasts distributed equally in the bottom 11 layers.6
Obtained and modified from Lee et al.6 with permission from Mary Ann Liebert. To see this illustration in color, the reader is referred to the web version of this
article at www.liebertpub.com/wound
3D PRINTING AND CELL THERAPY FOR WOUND REPAIR 151
skin tissue engineering has been shown by the
heightened control of cell density, organization, and
combining multiple cell types.
LIFT was applied in the development of 3D
spatially controlled constructs resembling human
skin and, in both instances, resulted in well-
organized tissue constructs. Koch et al. created a
bi-layered construct, containing murine fibroblasts
and human immortalized keratinocytes in Matri-
derm. Ten days of culture demonstrated proliferation
in all cells, which was used to verify the cell vital-
ity. Also, a layer of laminin, the main component of
the basal lamina, had formed in between the kera-
tinocyte and fibroblast layer. The formation of this
layer showed the increasing complexity that can
be formed by the 3D spatial arrangement of the
cells and the influence of multiple cell types in one
structure. The intra-cellular communication was
assessed by analysis of adherence and gap junc-
tions. Adherence junctions were found in abun-
dance between the keratinocytes, but to a lesser
extent between the fibroblasts.36 Similarly, Michael
et al. applied LIFT to fabricate a cellularized skin
substitute, assembling a construct containing 20
layers of keratinocytes on 20 layers of fibroblasts in
Matriderm. These constructs were tested in vivo in
full-thickness wounds in mice. All animals survived
the surgery and surrounding tissue connected with
the implanted skin substitute; no inflammatory or
necrotic processes were detected. Proliferation in
the epidermal and dermal layer was found in both
healthy mouse skin and the skin constructs, but not
in the negative control. In the skin substitute, a
blood vessel was formed after 11 days, but complete
vascularization was not achieved.52 Both studies
show LIFT as a promising technique in skin tissue
engineering, due to improved cellular spatial ar-
rangement, angiogenesis stimulation, and integra-
tion with host tissues.
Recently, extrusion printing was applied for the
development of skin substitutes. Kim et al. applied
a combination of gelatin and agar with extrusion
printing to create skin substitutes for the treat-
ment of laser tattoo removal.53 Multiple skin types
were emulated, with varying colors and light ab-
sorption, to accommodate multiple different skin
types. For all types, constructs were determined to
be of 138.5 – 0.1 lm and 0.81 – 0.04 mm thickness
for the epidermis and dermis, respectively, which is
relatively low, but within the range of native hu-
man skin.53 Cubo et al. printed a skin construct
with a dermal layer consisting of human dermal
fibroblasts, CaCl2, and human plasma.
2 Interest-
ingly, the authors applied a printing technique
whereby the ink is mixed during the printing pro-
cess. Directly afterward, human keratinocytes were
printed over the initial construct. The constructs
were left in incubation overnight, after which the
Figure 6. The visual appearance of a bioprinted graft in an immunodeficient mouse is shown in (A), and (B) shows a typical haematoxylin and eosin (H/E)-
stained sample of the bioprinted human skin grafts in immunodeficient mice and (C) shows a typical H/E-stained sample of native human skin, with the white
line indicating the dermo-epidermal junction (scale bar: 100 lm). Obtained and modified from Cubo et al.2 with permission from IOP Publishing. To see this
illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound
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constructs were implanted in immunodefi-
cient mice. The in vivo skin showed a
structure similar to human skin, contrast-
ing with the surrounding native mouse skin
(Fig. 6). Identified were the stratum basale,
stratum spinosum, stratum granulosum,
and stratum corneum, suggesting a normal
functioning epidermal layer. In addition,
neoangiogenesis formation was observed.2
Similarly, attempts have been made in
regard to the creation of an in situ bio-
printing technique, where human dermal
fibroblasts and human keratinocytes have been
loaded into a printer and printed directly on the
dorsa of athymic mice, resulting in complete clo-
sure of the wound after 3 weeks.54
Further optimization of bioprinting techniques
and combination with other biofabrication tech-
niques may lead to more complex tissue constructs,
best mimicking the organization of the skin and the
different ECM components in each layer.10
FUTURE DIRECTIONS
Bioprinting techniques show potential in ex-
panding current knowledge, in developing tissues
closer resembling native tissues, and in addres-
sing current skin tissue engineering complications
such as skin type differences, vascularization, and
cell organization. During the printing process, the
bioink formulation must be both stable and fluidic
enough to be extruded. After extrusion, the material
must be such that the printed structure retains
shape and provides mechanical behavior similar to
the specific tissue. The most common approach to
bioprinting involves cell encapsulation in a hydro-
gel, as the mechanical properties of the resulted
structure and water retention properties of most
hydrogels closely resemble the ECM. Therefore,
other biomolecules, such as growth factors, can be
added to the bioprinted constructs to influence epi-
thelialization, tissue formation, tissue remodeling,
and inflammation. Examples of biomolecules incor-
porated into hydrogels are VEGF in fibrin gels for
neural stem culture and the bioprinting of fibroblast
growth factor-2 and bone morphogenetic protein-2
onto sub-micron fibrous scaffolds to increase spatial
control of cells. Besides, the printing of growth fac-
tors onto a hydrogel in specific patterns can also
influence cell organization.54–56 Incorporation of
growth factors within micro particles, which are
combined with a bioink, improves release control.
Previously, VEGF-laden gelatin microparticles
have been incorporated into 3D printed constructs,
for a precise organization and sustained localized
release, resulting in heightened vessel formation in
mice compared with a fast release profile.57 More
recently, growth factors have been incorporated into
PLGA microparticles and printed in micrometer
scale resolutions.58 This type of microparticle-based
biomolecule inclusions could be customized and
applicable for different types of tissue regeneration
and can, therefore, also be explored in combination
with wound healing, thereby increasing targeting
precision, improving control of growth factor re-
lease, and creating the possibility of individualizing
the process based on patient need.
Predominantly vascularization within the con-
structs remains an important challenge in skin tis-
sue fabrication.3 The native dermis is a vascularized
tissue and can range between 0.3 and 4 mm in
thickness depending on the location. The epidermis
depends on the vascularization within the dermis
for its oxygen and nutrient exchange. Therefore, in
thicker multiple-layered constructs, there is often
necrosis of the epidermal layer. Significant ad-
vances in creating vascularized networks and 3D
printed structures will have to be made before the
development of large functional tissue constructs
can be realized. The introduction of several other
skin components, such as hair follicles, sweat
glands, and melanocytes, has yet to be realized.
SUMMARY
Bioprinting has been used to demonstrate the
potential to expedite skin tissue engineering. By
combining current knowledge on material science,
engineering, and cell biology, this interdisciplin-
ary approach can be applied to address current
limitations, especially in vascularization and skin
appendages, increasing reproducibility, and in-
creasing patient specificity. However, progression
can only be made through close collaboration be-
tween clinicians and researchers.
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11. Schäfer M, Werner S. Cancer as an overhealing
wound: an old hypothesis revisited. Nat Rev Mol
Cell Biol 2008;9:628–638.
12. McKinley M, O’Loughlin V, Bidle T, eds. Anatomy
& Physiology: An Integrative Approach, 2nd ed.
Columbus, OH, 2016:191.
13. Lee W, Debasitis JC, Lee VK, et al. Multi-layered
culture of human skin fibroblasts and keratino-
cytes through three-dimensional freeform fabri-
cation. Biomaterials 2009;30:1587–1595.
14. Pereira GG, Dimer FA, Guterres SS, Kechinski
CP, Granada JE, Cardozo NSM. Formulation and
characterization of poloxamer 407: thermo-
reversible gel containing polymeric microparticles
and hyaluronic acid. Quı́m Nova 2013;36:1121–1125.
15. Bhatnagar M, Bhatnagar A. Wound Dressings
from Algal Polymers. In: Kim SK, Chojnacka, K,
eds. Marine Algae Extracts: Processes, Products,
and Applications. Weinheim, Germany: Wiley-VCH
Verlag GmbH & Co: 2015:523–556.
16. Wood FM, Kolybaba ML, Allen P. The use of
cultured epithelial autograft in the treatment of
154 VAN KOGELENBERG ET AL.
major burn wounds: eleven years of clinical ex-
perience. Burns 2006;32:538–544.
17. Wood FM, Stoner ML, Fowler BV, Fear MW. The
use of a non-cultured autologous cell suspension
and Integra dermal regeneration template to
repair full thickness wounds in a porcine model: a
one step process. Burns 2007;33:693–700.
18. Boateng JS, Matthews KH, Stevens HN, Ec-
cleston GM. Wound healing dressings and drug
delivery systems: a review. J Pharm Sci 2007;97:
2892–2923.
19. Hrabchak C, Flynn L, Woodhouse KA. Biological
skin substitutes for wound cover and closure.
Expert Rev Med Devices 2006;3:373–385.
20. Groeber F, Holeiter M, Hampel M, Hinderer S,
Schenke-Layland K. Skin tissue engineering—
in vivo and in vitro applications. Adv Drug Deliv
Rev 2011;63:352–366.
21. Yildirimer L, Thanh NT, Seifalian AM. Skin re-
generation scaffolds: a multimodal bottom-up
approach. Trends Biotechnol 2012;30:638–648.
22. Kirchmajer DM, Gorkin III, R. An overview of
the suitability of hydrogel-forming polymers for
extrusion-based 3D-printing. J Mater Chem B
2015;3:4105–4117.
23. Chua AWC, Khoo YC, Tan BK, Tan KC, Foo CL,
Chong SJ. Skin tissue engineering advances in
severe burns: review and therapeutic applications.
Burns Trauma 2016;4:3.
24. Nyame TT, Chiang HA, Orgill DP. Clinical appli-
cations of skin substitutes. Surg Clin North Am
2014;94:839–850.
25. Briquez PS, Hubbell JA, Martino MM. Extra-
cellular matrix-inspired growth factor delivery
systems for skin wound healing. Adv Wound Care
2015;4:479–489.
26. Barrientos S, Stojadinovic O, Golinko MS, Brem H,
Tomic-Canic M. Growth factors and cytokines in
wound healing. Wound Repair Regen 2008;16:
585–601.
27. Gainza G, Villullas S, Pedraz JL, Hernandez RM, Ig-
artua M. Advances in drug delivery systems (DDSs) to
release growth factors for wound healing and skin
regeneration. Nanomedicine 2015;11:1551–1573.
28. Pachuau L. Recent developments in novel drug
delivery systems for wound healing. Expert Opin
Drug Deliv 2015;12:1895–1909.
29. Martin GD, Hoath SD, Hutchings IM. Inkjet
printing-the physics of manipulating liquid jets
and drops. J Phys Conf Ser 2008;105:012001.
30. Fang Y, Frampton JP, Raghavan S, et al. Rapid
generation of multiplexed cell cocultures using
acoustic droplet ejection followed by aqueous
two-phase exclusion patterning. Tissue Eng Part C
Methods 2012;18:647–657.
31. Demirci U. Acoustic picoliter droplets for emerging
applications in semiconductor industry and bio-
technology. J Microelectromechan Syst 2006;15:
957–966.
32. Cui X, Boland T, D’Lima DD, Lotz MK. Thermal
inkjet printing in tissue engineering and regener-
ative medicine. Recent Pat Drug Deliv Formul
2012;6:149–155.
33. Xu T, Gregory CA, Molnar P, et al. Viability and
electrophysiology of neural cell structures gener-
ated by the inkjet printing method. Biomaterials
2006;27:3580–3588.
34. Calvert P. Inkjet printing for materials and devices.
Chem Mater 2001;13:3299–3305.
35. Murphy SV, Atala A. 3D bioprinting of tissues and
organs. Nat Biotechnol 2014;32:773–785.
36. Koch L, Deiwick A, Schlie S, et al. Skin tissue
generation by laser cell printing. Biotechnol Bioeng
2012;109:1855–1863.
37. Schiele NR, Corr DT, Huang Y, Raof NA, Xie Y,
Chrisey DB. Laser-based direct-write techniques
for cell printing. Biofabrication 2010;2:032001.
38. Schiele NR, Chrisey DB, Corr DT. Gelatin-based
laser direct-write technique for the precise spatial
patterning of cells. Tissue Eng Part C Methods
2010;17;289–298.
39. Unger C, Gruene M, Koch L, Koch J, Chichkov BN.
Time-resolved imaging of hydrogel printing via
laser-induced forward transfer. Appl Phys A Mater
Sci Process 2011;103:271–277.
40. Gruene M, Deiwick A, Koch L, et al. Laser printing
of stem cells for biofabrication of scaffold-free
autologous grafts. Tissue Eng Part C Methods
2010;17:79–87.
41. Melchels FP, Dhert WJ, Hutmacher DW, Malda J.
Development and characterisation of a new bioink
for additive tissue manufacturing. J Mater Chem
B 2014;2:2282–2289.
42. Derby B. Inkjet printing of functional and struc-
tural materials: fluid property requirements, fea-
ture stability, and resolution. Annu Rev Mater Res
2010;40:395–414.
43. Ferris CJ, Stevens LR, Gilmore KJ, et al. Peptide
modification of purified gellan gum. J Mater Chem
B 2015;3:1106–1115.
44. Khalil S, Sun W. Biopolymer deposition for free-
form fabrication of hydrogel tissue constructs.
Mater Sci Eng C 2007;27:469–478.
45. Jakab K, Damon B, Neagu A, Kachurin A, Forgacs
G. Three-dimensional tissue constructs built by
bioprinting. Biorheology 2006;43:509–513.
46. Owens CM, Marga F, Forgacs G, Heesch CM.
Biofabrication and testing of a fully cellular nerve
graft. Biofabrication 2013;5:045007.
47. Mironov V, Visconti RP, Kasyanov V, et al. Organ
printing: tissue spheroids as building blocks. Bio-
materials 2009;30:2164–2174.
48. Mehesz AN, Brown J, Hajdu Z, et al. Scalable
robotic biofabrication of tissue spheroids. Bio-
fabrication 2011;3:025002.
49. Yu Y, Ozbolat IT. Tissue strands as ‘‘bioink’’ for
scale-up organ printing. Eng Med Biol Soc 2014;
2014:1428–1431.
50. Nikkhah M, Eshak N, Zorlutuna P, et al. Directed
endothelial cell morphogenesis in micropatterned
gelatin methacrylate hydrogels. Biomaterials
2012;33:9009–9018.
51. Lee JM, Yeong WY. Design and printing strate-
gies in 3D bioprinting of cell-hydrogels: a review.
Adv Healthc Mater 2016;5:2856–2865.
52. Michael S, Sorg H, Peck CT, et al. Tissue en-
gineered skin substitutes created by laser-
assisted bioprinting form skin-like structures in
the dorsal skin fold chamber in mice. PLoS One
2013;8:57741.
53. Kim H, Hau NT, Chae YG, Lee BI, Kang HW. 3D
printing-assisted fabrication of double-layered
optical tissue phantoms for laser tattoo treat-
ments. Lasers Surg Med 2016;48:392–399.
54. Campbell PG, Miller ED, Fisher GW, Walker LM,
Weiss LE. Engineered spatial patterns of FGF-2
immobilized on fibrin direct cell organization.
Biomaterials 2005;26:6762–6770.
55. Ker ED, Nain AS, Weiss LE, et al. Bioprinting of
growth factors onto aligned sub-micron fibrous
scaffolds for simultaneous control of cell differ-
entiation and alignment. Biomaterials 2011;32:
8097–8107.
56. Lee YB, Polio S, Lee W, et al. Bio-printing of collagen
and VEGF-releasing fibrin gel scaffolds for neural
stem cell culture. Exp Neurol 2010;223:645–652.
57. Poldevaart MT, Gremmels H, van Deventer K, et al.
Prolonged presence of VEGF promotes vasculari-
zation in 3D bioprinted scaffolds with defined ar-
chitecture. J Control Release 2014;184:58–66.
58. Tarafder MS, Koch A, Jun Y, Chou C, Awadallah
MR, Lee CH. Micro-precise spatiotemporal de-
livery system embedded in 3D printing for com-




ECM ¼ extracellular matrix
IL ¼ interleukin
LAB/LABP ¼ laser-assisted bioprinting
LIFT ¼ Laser-induced forward transfer
VEGF ¼ vascular endothelial growth factor
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